Cue Applies for EUA for Flu + COVID-19 Molecular Test
Cue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read MorePosted by Chris Wolski | Oct 4, 2022 | Covid 19, Flu & Respiratory Infections, Molecular Diagnostic Analyzers, POC Rapid Assays |
Cue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read MorePosted by Andy Lundin | Sep 21, 2022 | Company News, Diagnostic Technologies |
BrightInsight and bioMérieux announced a partnership to develop and bring to market a Clinical Digital Solution for diagnostics.
Read MorePosted by Andy Lundin | Sep 19, 2022 | Clinical Chemistry Analyzers, Immunoassay Instrumentation |
Roche received 510(k) clearance from the FDA for the cobas pure integrated solutions, new to the cobas family of Serum Work Area solutions.
Read MorePosted by Chris Wolski | Sep 15, 2022 | Covid 19 |
As new variants of the SARS-CoV-2 virus continue to emerge, concerns have been raised about the performance of rapid antigen tests.
Read MorePosted by Andy Lundin | Sep 9, 2022 | Covid 19 |
An interdisciplinary team of engineers and doctors are developing new technology designed to detect severe COVID complications.
Read More